Celldex Therapeutics Inc (NASDAQ: CLDX) Stock In Prove Me State
Celldex Therapeutics Inc (CLDX) concluded trading on Thursday at a closing price of $18.30, with 0.46 million shares of worth about $8.38 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -37.76% during that period and on April 17, 2025 the price saw a […]
Celldex Therapeutics Inc. (NASDAQ: CLDX): Hunting Genuine Value In Market Debris
Wellington Management Co. LLP recently announced the acquisition of new stake in Celldex Therapeutics Inc. (NASDAQ:CLDX). The institutional investor has increased its shareholding in the Healthcare company by 5.85% to 5.43 million shares with purchase of 0.3 million shares. This fresh investment now brings its stake to 9.93% valued currently at $164.1 million. In addition, […]
